Resistance to IL-1 anti-proliferative effect, accompanied by characteristics of advanced melanoma, permits invasion of human melanoma cells in vitro, but not metastasis in the nude mouse

International Journal of Cancer

Volumn 71, Issue 3, 1997, Pages 416-421

  Hayashi, Hidetoshi ^a   Shimizu, Reiko ^a   Fujii, Kaori ^a   Itoh, Saotomo ^a   Yang, De ^a   Onozaki, Kikuo ^a  

^a NAGOYA CITY UNIVERSITY   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

INTERCELLULAR ADHESION MOLECULE 1; INTERLEUKIN 6; INTERLEUKIN 8; METALLOPROTEINASE; RECOMBINANT INTERLEUKIN 1; RECOMBINANT INTERLEUKIN 6; VITRONECTIN RECEPTOR;

ARTICLE; CELL PROLIFERATION; CONTROLLED STUDY; DRUG MECHANISM; GROWTH INHIBITION; HUMAN; HUMAN CELL; IMMUNOMODULATION; MELANOMA CELL; METASTASIS POTENTIAL; MOLECULAR DYNAMICS; PRIORITY JOURNAL; RECEPTOR UPREGULATION; STRAIN DIFFERENCE;

ANIMALS; CELL DIVISION; CELL LINE; COLLAGENASES; DRUG RESISTANCE, NEOPLASM; FLOW CYTOMETRY; GELATINASES; HUMANS; INTERLEUKIN-1; INTERLEUKIN-6; INTERLEUKIN-8; MATRIX METALLOPROTEINASE 2; MATRIX METALLOPROTEINASE 9; MELANOMA; METALLOENDOPEPTIDASES; MICE; MICE, NUDE; NEOPLASM INVASIVENESS; NEOPLASM METASTASIS; RNA, MESSENGER; SKIN NEOPLASMS; TRANSCRIPTION, GENETIC; TRANSPLANTATION, HETEROLOGOUS; TUMOR CELLS, CULTURED;

EID: 0030958492     PISSN: 00207136     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1097-0215(19970502)71:3<416::AID-IJC19>3.0.CO;2-D     Document Type: Article

References (28)

1. ARAKI, M., YANO, T., HAYASHI, H., TAKII, T., SUZUKI, K. and ONOZAKI, K., Resistance to the anti-proliferative effect of IL-1 on human melanoma cell line is associated with endogenous production of 1L-1 and 1L-6. Int. J. Cancer., 56, 275-280 (1994).
2. BALLIN, M., GOMEZ, D.E., SINHA, C.C. and THORGEIRSSON, U .P. rasoncogene-mediated induction of a 92-kDa metaltoproteinase: strong correlation with the malignant phenotype. Biochem. biophys. Res. Commun., 154, 832-838 (1988)
3. BENNICELLI, J.L., ELIAS, J., KERN, J. and GUERRY, D., Production of interleukin-1 activity by cultured human melanoma cells. Cancer Res., 49, 930-935 (1989).
4. 3 antagonists promote tumor regression by inducing apoptosis of angiogenic blood vessels. Cell, 79, 157-1164 (1994).
5. 3. Cell, 85, 683-693 (1996).
6. CHOMCZYNSKI, D. and SACCHI, N., Single-step method of RNA isolation by acid-guanidium-thiocyanate-phenol-chloroform extraction. Anal. Biochem., 162, 156-159 (1987).
7. COZZOLINO, F., RUBARTELLI, A., ALDINUCCI, D., SITICE, R., TORCICE, M., SHAW, A., and Di GUGLIELMO, R., Interleukin 1 as an autocrine growth factor for acute myeloid leukemia cells. Proc. nat. Acad. Sci. (Wash.), 86, 2369-2373 (1989).
8. DELARCO, J.E., PIGOTT, D.A. and LAZARUS, J.A., Ectopic peptides released by a human melanoma cell lines that modulate the transformed phenotype. Proc. nat. Acad. Sci. (Wash.), 82, 5015-5019 (1985).
9. ENDO, Y., MATSUSHIMA, K. and OPPENHEIM, J.J., Mechanism of in vitro anti-tumor effects of interleukin 1 (IL-1). Immunobiol., 172, 316-322 (1986).
10. ENSOLI, B., NAKAMURA, S., SALAHUDDIN, S.Z., BIBERFELD, P., LARSSON, L., BEAVER, B., WONG-STAAL, F. and GALLO, R.C., AIDS-Kaposi's sarcoma-derived cells express cytokines with autocrine and paracrine growth effects. Science, 243, 223-226 (1989).
11. KERBEL, R.S., Expression of multi-cytokine resistance and multi-growth-factor independence in advanced-stage metastatic cancer. Malignant melanoma as a paradigm. Amer, J. Pathol., 141, 519-524 (1992).
12. KLEINER, D.E., and STETLKR-STEVENSON, W.G., Structural biochemistry and characteristics of matrix metalloproteinase. Curt: Opin. Cell Biol. 5, 891-897 (1993).
13. Lu, C., VICKERS, M.F. and KERBEL, R.S., Interleukin 6: a fibroblast- derived growth inhibitor of human melanoma cells from early but not advanced stages of tumor progression. Proc. nat. Acad. Sci. (Wash.), 89, 9215-9219 (1992).
14. MACDOUGALL, J.R., BANI, M.R., LIN, Y. RAK, J. and KURBEL, R.S., The 92-kDa gelatinase B is expressed by advanced-stage melanoma cells: suppression by somatic cell hybridization with early-stage melanoma cells. Cancer Res., 55, 4174-4181 (1995).
15. MORINAGA, Y., SUZUKI, H., TAKATSUKI, F., AKIYAMA, T., MATSUSHIMA, K. and ONOZAKI, K., Contribution of IL-6 to the anti-proliferative effect of IL-l and tumor necrosis factor on tumor cell lines. J. Immunol., 143, 3538-3542 (1989).
16. NAKAJIMA, M., MORIKAWA, K., FABRA, A., BUCANA, C.D. and FIDLER, I.J., Influence of organ environment on extracellular-matrix degradative activity and metastasis of human colon-carcinoma cells. J. nat. Cancer Inst., 82, 1890-1898 (1990).
17. NATALI, P., NICOTRA, M.R., CAVALIERE, R., BIGOTTI, A., ROMANO, G., TEMPONI, M. and FERRONE, S,. Differential expression of intercellular adhesion molecule 1 in primary and metastic melanoma lesions. Cancer Res., 50, 1271-1278 (1990).
18. ONOZAKI, K., MATSUSHIMA, K. and AGGARWAL, B.B., Human interleukin 1 is a cytocidal factor for several tumor cell lines. J. Immunol., 135, 3962-3968 (1985).
19. RODECK, U., MELBER, K., KATH, R., MENSSEN, H.D., VARELLO, M., ATKINSON, B., and HERLYN, M., Constitutive expression of multiple- growth-factor genes by melanoma cells but not normal melanocytes. J. invest. Dermatol., 97, 20-26 (1991)
20. SCHADENDORF, D., MÖLLER A., ALGERMISSEN, B., WORM, M., STICHERLING, M. and CZARNETZKI, B.M., IL-8 produced by human malignant melanoma cells in vitro is an essential autocrine growth factor. J. Immunol., 151, 2667-2675 (1993).
21. SINGH, R.K., GUTMAN, M., RADINSKY, R., BANA, C.D. and FIDLER I.J., Expression of interleukin 8 correlates with the metastatic potential of human melanoma cells in nude mice. Cancer Res., 54, 3242-3247 (1994).
22. SWOPE, V.B., ABDEL, M.Z., KASSEN, L.M. and NORDLUND, J.J., Interleukin-1 alpha and 6 and tumor-necrosis factor alpha are paracrine inhibitors of human melanocyte proliferation and melanogenesis. J. invest. Dermatol., 96, 180-185 (1991).
23. TANAKA, T., TSUDO, M., KARASUYAMA, H., KITAMURA, F., KONO, T., HATAKEYAMA, M., TANIGUCHI, T. and MIYASAKA M., A novel monoclonal antibody against murine IL-2-receptor beta chain. Characterization of receptor expression in normal lymphoid cells and EL-4 cells. J. Immunol., 147, 2222-2228 (1991).
24. TEMPONI, M., ROMANO, G., D'URSO, C.M., WANG, Z., KEKISH, U. and FERRONE, S., Profile of intercellular adhesion molecule-1 (ICAM-1) synthesized by human melanoma cell lines. Sem. Oncol., 15, 595-607 (1988).
25. TSUJISAKI, M., IMAI, K., HIRATA, H., HANAZAWA, Y. MASUYA, J., NAKANO, T., SUGIYAMA, T., MATSUI, M., HINODA, Y. and YACHI, A., Detection of circulating intercellular adhesion molecule-1 antigen in malignant diseases. Clin, exp. Immunol., 85, 3-8 (1991).
26. USUI, N., MIMNAUGH, E.G., and SINHA, B.K., A role for the interleukin-1 receptor in the synergistic anti-tumor effects of human interleukin 1α and etoposide against human melanoma cells. Cancer Res., 51, 769-774 (1991).
27. WELCH, D.R., BISI, J.E., MILLER, B.E., CONAWAY, D., SEFTOR, E.A., YOHEM, K.H., GILMORE, L.B., SEFTOR, R.E.B., NAKAJIMA, M. and HENDRIX, M.J.C., Characterization of a highly invasive and spontaneously metastatic human malignant-melanoma cell line. Int. J. Cancer, 47, 227-237 (1991).
28. YANO, S., NISHIOKA, Y., IZUMI, K., TSURUO, TANAKA, T., MIYASAKA, M. and SONE, S., Novel metastasis model of human lung cancer in SCID mice depleted of NK cells. Int. J. Cancer, 67, 211-217 (1996).